Cargando…
Effects of rebamipide for chronic atrophic gastritis: A protocol for systematic review and meta-analysis
BACKGROUND: Chronic atrophic gastritis (CAG) is defined as an important precancerous disease with high risk of gastric cancer. Rebamipide is a mucosal protective agent widely used in the treatment of chronic gastritis. The aim of this systematic review is to assess the efficacy and safety of rebamip...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310858/ https://www.ncbi.nlm.nih.gov/pubmed/32569191 http://dx.doi.org/10.1097/MD.0000000000020620 |